“Episode 122: The Pathway to Sustainable Market Share for Pharma, and Other Life Sciences Companies with Dave Dierk of Aventria Health Group”
by Stacey Richter

Listen to the MP3 file directly by clicking here.

A 27-year veteran of managed-markets marketing, David is the President/CEO of Pinnacle Health Communications. After working in consumer marketing with AT&T and healthcare publishing with Elsevier, David made the move to medical advertising and communications at K.I. Lipton, Inc. Subsequently, he became a cofounder of Pinnacle. David is an accomplished strategist, providing innovative customer marketing, access, quality, and health intervention solutions for large clients and has directed the development of numerous industry-leading campaigns in primary care and specialty markets. He has supported clients in disease areas that include oncology (Bristol Myers Squibb [BMS], Novartis, Eisai), virology (BMS, Merck & Co.), pharmacy (American Pharmacists Association, Merck, Novartis), and blood disorders (Novo Nordisk), to name a few. David has helped more than 15 clients achieve top rankings in their respective categories. He is also an active member of the Pharmacy Quality Alliance.


00:00 Comparing Pharma and Life Sciences to Tech Companies is like comparing apples to oranges.
03:15 “People are hedging their bets relative to where the volume sits.”
03:30 “What does inviting less risk mean?”
04:20 Making informed decisions based on Market Shift Data.
06:20 The doubling number of customers intending to adopt Value-Based Care Reimbursement Initiatives.
06:50 “Timing is what’s paramount here.”
07:30 Customers don’t only want to talk about brands, they want to talk Patient Care and Optimizing Outcomes.
08:10 “How are you Customer-Centric if you’re leading every conversation with the brand?”
10:00 Patient Care, Patient Outcomes, Market Share, Profitability and Reimbursement.
13:15 “Don’t presume that your timeline equates to their timeline.”
14:30 “What is the most conservative approach?”
14:50 “It’s a question of When, and To What Degree?”
17:00 The best way forward with Evidence-Based Pathways.
19:45 “Pharma does have a lot to offer.”
21:30 “Is there a Point of Prescribing?”
23:30 You can find out more information at aventriahealth.com.